XML 103 R26.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Reporting
12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Segment Reporting
Segment Reporting

Prior to the Sheridan acquisition, the Company operated its centers as individual components of one operating and reportable segment. Upon completion of the Sheridan acquisition, the Company operates in two major lines of business - the operation of ambulatory surgery centers and providing multi-specialty outsourced physician services, which have been identified as its operating and reportable segments. Through the ambulatory services segment, the Company acquires, develops and operates ambulatory surgery centers in partnership with physicians. Through the physician services segment, the Company provides outsourced physician services in multiple specialties to hospitals, ambulatory surgery centers and other healthcare facilities, primarily in the areas of anesthesiology, children’s services, emergency medicine and radiology.

The Company’s financial information by operating segment is prepared on an internal management reporting basis that the chief operating decision maker uses to allocate resources and assess the performance of the operating segments. The Company’s operating segments have been defined based on the separate financial information that is regularly produced and reviewed by the Company’s chief operating decision maker which is its Chief Executive Officer.

The following table presents financial information for each reportable segment (in thousands):
 
Year ended December 31,
 
2014
 
2013
 
2012
Net Revenue:
 
 
 
 
 
Ambulatory Services
$
1,109,935

 
$
1,057,196

 
$
899,245

Physician Services
512,014

 

 

Total
$
1,621,949

 
$
1,057,196

 
$
899,245

 
 
 
 
 
 
Adjusted Segment EBITDA:
 
 
 
 
 
Ambulatory Services
$
197,377

 
$
187,972

 
$
154,527

Physician Services
107,105

 

 

Total
$
304,482

 
$
187,972

 
$
154,527

 
 
 
 
 
 
Adjusted Segment EBITDA:
$
304,482

 
$
187,972

 
$
154,527

Earnings from continuing operations attributable to noncontrolling interests
190,809

 
183,484

 
155,661

Interest expense, net
(83,285
)
 
(29,525
)
 
(16,950
)
Depreciation and amortization
(60,344
)
 
(32,400
)
 
(29,255
)
Share-based compensation
(10,104
)
 
(8,321
)
 
(6,692
)
Transaction costs
(33,890
)
 
(300
)
 
(700
)
Debt extinguishment costs
(16,887
)
 

 

Gain on deconsolidation
3,411

 
2,237

 

Earnings from continuing operations before income taxes
$
294,192

 
$
303,147

 
$
256,591

 
 
 
 
 
 
Acquisition and Capital Expenditures:
 
 
 
 
 
Ambulatory Services (1)
$
81,156

 
$
102,450

 
$
306,252

Physician Services
28,909

 

 

Total
$
110,065

 
$
102,450

 
$
306,252

 
2014
 
2013
Assets:
 
 
 
Ambulatory Services
$
2,528,525

 
$
2,177,944

Physician Services
2,994,999

 

Total
$
5,523,524

 
$
2,177,944

                                    
(1)
Excludes the purchase price to acquire Sheridan.